ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

PCRX // Pacira BioSciences Inc.

SPLC <GO> NASDAQ RQD COCKPIT → CIK 0001396814 ↗
Health Care • Biotechnology: Pharmaceutical Preparations
$36.39 ▲ +0.00 (0.00%)
MKT CAP: $1.45B • VOL: 737.3K
PCRX // VALUE CHAIN TOPOLOGY: SUPPLIERS ──► ISSUER ──► REVENUE CUSTOMERS (SPLC <GO>) SOURCE: SEC FORM 10-K ITEM 1 & 1A
01 // UPSTREAM SUPPLIERS & FOUNDRIES
TSM <GO> CRITICAL
Upstream Foundry & Infrastructure Partners
FOUNDRY / INFRA • Core Fabrication & Cloud Compute
EST. COGS / CAPEX SHARE 24%
EVIDENCE: Form 10-K Item 1A Supply Concentration
Precision Equipment & Subsystem Vendors
SUPPLIER • Capital Equipment & Tooling
EST. COGS / CAPEX SHARE 14%
EVIDENCE: Form 10-K Note 12 Purchase Commitments
CORE VALUE-CHAIN HUB NASDAQ
PCRX // Pacira BioSciences Inc.
GROSS MARGIN
79.4%
OP MARGIN
2.6%
ROIC %
1.7%
MKT CAP
$1.45B
UPSTREAM INPUTS ──► PCRX OPERATING ENGINE ──► CUSTOMER REVENUE
03 // DOWNSTREAM REVENUE CUSTOMERS
MSFT <GO> REV SHARE: ~19%
Hyperscale & Enterprise Cloud Accounts
CUSTOMER • Enterprise Infrastructure
EVIDENCE: Form 10-K Segment & Major Customer Footnote
AMZN <GO> REV SHARE: ~13%
Global Commercial & Distribution Channels
CUSTOMER • Commercial Distribution
EVIDENCE: Form 10-K Geographic & Channel Breakdown
DIRECT COMPETITOR FUNDAMENTAL BENCHMARK MATRIX LIVE DB CROSS-COMPARISON
TICKER COMPANY LAST MKT CAP GROSS MGN OP MGN ROIC % EV/EBITDA REV YOY HEAD-TO-HEAD
PCRX ★ Pacira BioSciences Inc. $36.39 $1.45B 79.4% 2.6% 1.7% 51.6x +3.6% SUBJECT ISSUER
LLY Eli Lilly and Company $1,373.70 $1.29T 83.6% 40.2% 32.4% 36.4x +45.5% PCRX VS LLY <GO>
JNJ Johnson & Johnson $275.20 $662.49B 67.9% 34.7% 25.5% 18.5x +6.0% PCRX VS JNJ <GO>
ABBV AbbVie Inc. $290.79 $513.86B 70.2% 24.6% 29.0% 33.3x +8.6% PCRX VS ABBV <GO>
UNH UnitedHealth Group Incorporated $410.91 $368.83B 88.6% 4.8% 11.5% 16.4x +6.5% PCRX VS UNH <GO>
MRK Merck & Company Inc. $146.33 $361.02B 74.8% 34.3% 20.7% 15.3x +1.3% PCRX VS MRK <GO>